000 | 01121 a2200241 4500 | ||
---|---|---|---|
005 | 20250516091109.0 | ||
264 | 0 | _c20120514 | |
008 | 201205s 0 0 eng d | ||
022 | _a1477-092X | ||
024 | 7 |
_a10.1177/1078155212439813 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
245 | 0 | 0 |
_aAbstracts of the XIII Symposium of the International Society of Oncology Pharmacy Practitioners. May 9-11, 2012. Melbourne, Australia. _h[electronic resource] |
260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cJun 2012 |
||
300 |
_a3-24 p. _bdigital |
||
500 | _aPublication Type: Congress; Overall | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMedical Oncology |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aPharmacy |
773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 18 _gno. 2 Suppl _gp. 3-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155212439813 _zAvailable from publisher's website |
999 |
_c21742229 _d21742229 |